Key factors include baseline body weight, adherence to reduced-calorie diet and increased physical activity, presence of type 2 diabetes (which typically results in less weight loss), concurrent medications affecting appetite or metabolism, and individual tolerance to gastrointestinal side effects
Sources Government of Ontario
This approach focuses on: Clear, Upfront Pricing $149/mo every month Save $30 $387 quarterly Save $150 $714 every 6mo Save $360 $1,308 annually Save $840 $149 $149/mo every month Save $30 $129 $387 quarterly Save $150 $119 $714 every 6mo Save $360 $109 $1,308 annually Save $840 $179 $179/mo every month Save $30 $159 $477 quarterly Save $150 $149 $894 every 6mo Save $360 $139 $1,668 annually Save $840 $149 $149/mo every month Save $30 $129 $387 quarterly Save $150 $119 $714 every 6mo Save $360 $109 $1,308 annually Save $840 Switch to Lttl And Keep Your Current Dose No surprises
The maximum semaglutide dose for weight management is 2.4 mg weekly (Wegovy dosing)
Orforglipron is under assessment for the management of obesity and T2D and may provide a competitive alternative to oral semaglutide, with less burdensome administration, as it does not require to be taken at a fasting state [24]